Paycor HCM Inc (NASDAQ: PYCR) closed the day trading at $18.25 down -3.23% from the previous closing price of $18.86. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 937680 shares were traded.
Ratios:
For a better understanding of PYCR, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 52.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.27. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on February 06, 2024, initiated with a Buy rating and assigned the stock a target price of $26.
On January 05, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $27 to $22.
On November 07, 2023, UBS started tracking the stock assigning a Neutral rating and target price of $20.UBS initiated its Neutral rating on November 07, 2023, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 ’24 when PRIDE GP, INC. sold 8,000,000 shares for $20.05 per share. The transaction valued at 160,368,000 led to the insider holds 0 shares of the business.
Geene Alice L sold 1,428 shares of PYCR for $28,780 on Jan 19 ’24. The insider now owns 111,543 shares after completing the transaction at $20.15 per share. On Jan 16 ’24, another insider, Corr Jonathan, who serves as the Director of the company, sold 1,508 shares for $19.66 each. As a result, the insider received 29,647 and left with 19,988 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PYCR now has a Market Capitalization of 3.25B and an Enterprise Value of 3.20B. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.37 while its Price-to-Book (P/B) ratio in mrq is 2.56. Its current Enterprise Value per Revenue stands at 5.30 whereas that against EBITDA is 55.20.
Stock Price History:
Over the past 52 weeks, PYCR has reached a high of $27.50, while it has fallen to a 52-week low of $17.13. The 50-Day Moving Average of the stock is 19.94, while the 200-Day Moving Average is calculated to be 21.83.
Shares Statistics:
Over the past 3-months, PYCR traded about 698.15K shares per day on average, while over the past 10 days, PYCR traded about 631.5k shares per day. A total of 176.54M shares are outstanding, with a floating share count of 80.20M. Insiders hold about 54.95% of the company’s shares, while institutions hold 40.96% stake in the company. Shares short for PYCR as of Mar 15, 2024 were 9.56M with a Short Ratio of 13.69, compared to 9.39M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.37% and a Short% of Float of 14.62%.
Earnings Estimates
Current recommendations for the stock of the company come from 17 analysts. On average, analysts expect EPS of $0.2 for the current quarter, with a high estimate of $0.23 and a low estimate of $0.19, while EPS last year was $0.18. The consensus estimate for the next quarter is $0.09, with high estimates of $0.12 and low estimates of $0.08.
Analysts are recommending an EPS of between $0.52 and $0.43 for the fiscal current year, implying an average EPS of $0.47. EPS for the following year is $0.55, with 16 analysts recommending between $0.69 and $0.48.
Revenue Estimates
A total of 18 analysts have provided revenue estimates for PYCR’s current fiscal year. The highest revenue estimate was $658.2M, while the lowest revenue estimate was $650.97M, resulting in an average revenue estimate of $653.94M. In the same quarter a year ago, actual revenue was $552.69M, up 18.30% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $760.95M in the next fiscal year. The high estimate is $829.82M and the low estimate is $745M. The average revenue growth estimate for next year is up 16.40% from the average revenue estimate for this year.
